Necrosis Targeted Radiotherapy With Iodine-131-Labeled Hypericin to Improve Anticancer Efficacy of Vascular Disrupting Treatment in Rabbit VX2 Tumor Models
Oncotarget - United States
doi 10.18632/oncotarget.3679
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 29, 2015
Authors
Publisher
Impact Journals, LLC